Cargando…
Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy
PURPOSE: Central serous chorioretinopathy (CSCR) is a complex ocular entity that, in its chronic form, can lead to serious visual impairment and morphological damage to the retina. The aim of the current retrospective study was to evaluate the damage present after long-standing but resolved central...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659242/ https://www.ncbi.nlm.nih.gov/pubmed/31345183 http://dx.doi.org/10.1186/s12886-019-1171-5 |
_version_ | 1783439096114315264 |
---|---|
author | Gawęcki, Maciej Jaszczuk-Maciejewska, Agnieszka Jurska-Jaśko, Anna Kneba, Małgorzata Grzybowski, Andrzej |
author_facet | Gawęcki, Maciej Jaszczuk-Maciejewska, Agnieszka Jurska-Jaśko, Anna Kneba, Małgorzata Grzybowski, Andrzej |
author_sort | Gawęcki, Maciej |
collection | PubMed |
description | PURPOSE: Central serous chorioretinopathy (CSCR) is a complex ocular entity that, in its chronic form, can lead to serious visual impairment and morphological damage to the retina. The aim of the current retrospective study was to evaluate the damage present after long-standing but resolved central serous chorioretinopathy and refer it to healthy individuals. Correlations between measurable factors—for example, duration of the disease, baseline retinal morphological parameters, or patient age and/or their degree of impairment—were also assessed. MATERIALS AND METHODS: The study group consisted of thirty-two eyes (13 female and 19 male, mean age 49.6 years SD +/− 10.5) with chronic central serous chorioretinopathy (mean duration 18.9 months SD +/− 15.4) in which complete resolution of subretinal fluid was achieved after subthreshold micropulse laser treatment. Inclusion criterion was a lack of subretinal fluid within the whole area of the central retina scanned by the spectral domain optical coherence tomography. The group was extracted out of 51 cases of chronic CSCR that were treated with that method. They were analyzed according to final best-corrected visual acuity and retinal morphological parameters as measured by spectral optical coherence tomography with angiography option (OCTA). Results were compared with the outcomes of a control group, which consisted of 40 eyes of healthy individuals with full distance visual acuity (0.0 logMAR, 1.0 Snellen) never treated with subthreshold micropulse laser. Statistical analysis included regarding correlation between final visual acuity and final central retinal thickness and retinal and functional parameters prior to treatment. RESULTS: Final best-corrected visual acuity after chronic central serous chorioretinopathy was 0.23 logMAR (0.6 Snellen) and central retinal thickness was 39.32 μm smaller than in controls. No correlation was found between final visual acuity and retinal thickness and duration of the disease, patient age, and baseline morphological retinal parameters. OCTA scans revealed impaired choriocapillaries flow signal even following resolution of the disease. CONCLUSION: Chronic central serous chorioretinopathy is a potentially damaging clinical entity that results in serious visual impairment, retinal thinning, and choroidal flow defects. Further research is needed to determine precisely the timepoint of this damage. |
format | Online Article Text |
id | pubmed-6659242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66592422019-08-01 Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy Gawęcki, Maciej Jaszczuk-Maciejewska, Agnieszka Jurska-Jaśko, Anna Kneba, Małgorzata Grzybowski, Andrzej BMC Ophthalmol Research Article PURPOSE: Central serous chorioretinopathy (CSCR) is a complex ocular entity that, in its chronic form, can lead to serious visual impairment and morphological damage to the retina. The aim of the current retrospective study was to evaluate the damage present after long-standing but resolved central serous chorioretinopathy and refer it to healthy individuals. Correlations between measurable factors—for example, duration of the disease, baseline retinal morphological parameters, or patient age and/or their degree of impairment—were also assessed. MATERIALS AND METHODS: The study group consisted of thirty-two eyes (13 female and 19 male, mean age 49.6 years SD +/− 10.5) with chronic central serous chorioretinopathy (mean duration 18.9 months SD +/− 15.4) in which complete resolution of subretinal fluid was achieved after subthreshold micropulse laser treatment. Inclusion criterion was a lack of subretinal fluid within the whole area of the central retina scanned by the spectral domain optical coherence tomography. The group was extracted out of 51 cases of chronic CSCR that were treated with that method. They were analyzed according to final best-corrected visual acuity and retinal morphological parameters as measured by spectral optical coherence tomography with angiography option (OCTA). Results were compared with the outcomes of a control group, which consisted of 40 eyes of healthy individuals with full distance visual acuity (0.0 logMAR, 1.0 Snellen) never treated with subthreshold micropulse laser. Statistical analysis included regarding correlation between final visual acuity and final central retinal thickness and retinal and functional parameters prior to treatment. RESULTS: Final best-corrected visual acuity after chronic central serous chorioretinopathy was 0.23 logMAR (0.6 Snellen) and central retinal thickness was 39.32 μm smaller than in controls. No correlation was found between final visual acuity and retinal thickness and duration of the disease, patient age, and baseline morphological retinal parameters. OCTA scans revealed impaired choriocapillaries flow signal even following resolution of the disease. CONCLUSION: Chronic central serous chorioretinopathy is a potentially damaging clinical entity that results in serious visual impairment, retinal thinning, and choroidal flow defects. Further research is needed to determine precisely the timepoint of this damage. BioMed Central 2019-07-25 /pmc/articles/PMC6659242/ /pubmed/31345183 http://dx.doi.org/10.1186/s12886-019-1171-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Gawęcki, Maciej Jaszczuk-Maciejewska, Agnieszka Jurska-Jaśko, Anna Kneba, Małgorzata Grzybowski, Andrzej Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy |
title | Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy |
title_full | Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy |
title_fullStr | Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy |
title_full_unstemmed | Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy |
title_short | Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy |
title_sort | impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659242/ https://www.ncbi.nlm.nih.gov/pubmed/31345183 http://dx.doi.org/10.1186/s12886-019-1171-5 |
work_keys_str_mv | AT gaweckimaciej impairmentofvisualacuityandretinalmorphologyfollowingresolvedchroniccentralserouschorioretinopathy AT jaszczukmaciejewskaagnieszka impairmentofvisualacuityandretinalmorphologyfollowingresolvedchroniccentralserouschorioretinopathy AT jurskajaskoanna impairmentofvisualacuityandretinalmorphologyfollowingresolvedchroniccentralserouschorioretinopathy AT knebamałgorzata impairmentofvisualacuityandretinalmorphologyfollowingresolvedchroniccentralserouschorioretinopathy AT grzybowskiandrzej impairmentofvisualacuityandretinalmorphologyfollowingresolvedchroniccentralserouschorioretinopathy |